Global Regenerative Medicine Market - 2022-2029

Market Overview

The Global Regenerative Medicine Market is expected to grow at a high CAGR of 26.70% during the forecasting period (2022-2029).

Regenerative medicine is an emerging field that aims to repair and replace damaged organs and tissues. It is potential for the treatment of chronic diseases and disorders, such as Alzheimer's disease, diabetes, and others. Regenerative medicine is an interdisciplinary field that applies engineering and life science principles to encourage regeneration. It can restore diseased and injured tissues and whole organs.

Market Dynamics

The global regenerative medicine market growth is driven by the rising prevalence of chronic diseases and genetic disorders. Other factors are the increase in global healthcare expenditure, rapid growth in the aging population, and an increase in government & private funding to support the development of regenerative medicine.

The growing prevalence of chronic diseases, genetic disorders, and cancer will drive the market growth

The incidence and prevalence of chronic diseases such as CVD, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased significantly across the globe, over the last few decades. The increased incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, can be a result of diabetes and obesity, which will require treatments and incur exorbitant medical expenses.

The market is found experiencing the major technological advancements in biologics, biomaterials, stem cell technology, and tissue engineering, thus contributing to the market growth. There are also various recent advancements in regenerative medicine, including the regenerated tracheas for transplant, 3D bioprinting, stem cell treatments for vision loss, and stem cell treatments for heart repair.

The current market is also witnessing extensive R&D activities. Apart from the R&D activities being conducted by private players, there is significant involvement of academic institutions in conducting various research. Therefore, in the future, several new biotech and med-tech companies are expected to come up, as the result of the current R&D endeavors across the world.

Growing research and development by the organizations to discover innovative medicine will significantly influence the regenerative medicine market expansion. The industry has observed significant growth in research funding over the past few years. For instance, as per the Alliance for Regenerative Medicine, overall financing increased from USD 9.8 billion in 2019 to USD 19.9 billion in 2020. Rising funding has further allowed organizations to strengthen their product development capabilities, thereby augmenting the market growth in the forecast period.

The high cost of cell and gene therapies will hamper the growth of the market

Patients suffering from terminal illnesses and serious disorders require cell and gene therapies which represent a significant scientific and medical advancement. These therapies are helping to transform how diseases are treated and potentially cured. Furthermore, such therapies will eventually enable doctors and medical professionals to infuse genes/cells via injectable means in order to avoid a series of drugs and multiple surgeries in patients. However, despite the fact of these therapies are lifesavers and more effective compared to the traditional treatments, the response in terms of demand for these therapies is less compared to the anticipation. This can be attributed to the high costs of these therapies and the difficulty in obtaining reimbursements and coverage for these therapies.

COVID-19 Impact Analysis

The COVID-19 outbreak will impact the regenerative medicine market in the initial phase of the forecast period. Due to nationwide lockdowns, denied wound care services, canceled or postponed elective surgeries, and increasing skin injuries in COVID-19 medical care providers, the regenerative medicine market is expected to register a certain decline during the forecast period. However, during the latter half of the forecast period, the demand for regenerative medicine products is expected to rise drastically. Singapore-based Duke-NUS medical school's emerging infectious diseases research program demonstrated the utility of these immunotherapies in treating patients with COVID-19 infection. The presence of several programs and continuous investments by government and private agencies to support R&D also accelerate the industry's progress.

Segment Analysis

The dermatology segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Dermatology is estimated to have the largest share of revenue generation, and this high contribution is attributed to the presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Therefore, there is a broad range of products present, from patches to cure small injuries to matrix and grafts for chronic wounds and burns. Thus, the segment is expected to continue to dominate the market through the forecast period.

The increasing number of accidents and bone defects is also expected to drive the regenerative medicine market. There are also several research studies that are being conducted on tissue engineering for the development of bone graft substitutes, with the help of regenerative medicine. So, with the new advances in bone grafts, the market is expected to grow over the forecast period.

Geographical Analysis

North America region holds the largest market share of the global regenerative medicine market

North America is estimated to have the largest share, in terms of revenue, owing to the presence of major players and rapid advances in technology, along with high investments in stem cell and oncology research. There is also an increasing prevalence of diseases, such as cancer and diabetes, which can now be cured by various stem cell therapies. Additionally, the awareness regarding the available stem cell procedures and therapies among people is rising, which in turn, is increasing the demand for the overall market. Moreover, its broad base of the patient population and the presence of significant medical companies along with the extensive research activities undertaken by a majority of prominent local players contribute to the growth of North America's share in the regenerative medicine market.

The high investment and funding to support the development of regenerative medicine. Availability of funds as well as several initiatives by the government & private organizations contributes to the highest revenue flow from the U.S. For instance, the "2020: A New Vision" initiative of the U.S. Department of Health and Human Services recognizes regenerative medicine at the forefront of healthcare. These factors are driving the growth of the market in the region.

Competitive Landscape

The regenerative medicine market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Allergan Plc, Osiris Therapeutics (Smith & Nephew), Integra Lifesciences, Cook Biotech Incorporated, and Organogenesis Inc., Baxter, Medtronic Plc, Thermo Fisher Scientific, Sigma-Aldrich Co., Becton Dickinson and Company among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the regenerative medicine market globally. For instance, in January 2018, RepliCel Life Sciences Inc. formed a partnership with the private firm, China-based Yofoto Health Industry Co. Ltd for regenerative medicine. This partnership builds on RepliCel's existing alliance in Japan with Shiseido. Yofoto intents to expand into more scientifically sophisticated markets, including gene-based blood testing and regenerative medicine, and in establishing its network of wellness clinics in partnered geographies.

Osiris Therapeutics

Overview:

The company's therapeutic areas focus on innovation in regenerative medicine, including bioengineering, stem cell research, and viable tissue-based products, intended to improve the health and lives of patients and lower overall healthcare costs.

Product Portfolio:

PuraPly Antimicrobial (PuraPly AM): PuraPly AM Wound Matrix is cleared Class II medical device that is indicated for the management of a variety of acute and chronic wounds, including partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, trauma wounds, draining wounds, and first- and second-degree burns.

Why Purchase the Report?

Visualize the composition of the global regenerative medicine market segmentation by therapy type, product, application, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global regenerative medicine market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global regenerative medicine market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global regenerative medicine market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 190 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Regenerative Medicine Market - By Therapy Type

Cell Therapy

GeneTherapy

Tissue Engineering

StemCell

Others

Global Regenerative Medicine Market - By Product

AutologousCell Based Products

Allogeneic Cell-Based Products

Acellular Products

Global Regenerative Medicine Market - By Application

Cardiovascular

Oncology

Dermatology

Musculoskeletal

Neurology

Others

Global Regenerative Medicine Market - By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America